OCI NV (OCI.AS)

NL0010558797 - Common Stock

26.39  +1.62 (+6.54%)

Fundamental Rating

4

Taking everything into account, OCI scores 4 out of 10 in our fundamental rating. OCI was compared to 62 industry peers in the Chemicals industry. OCI has an excellent profitability rating, but there are some minor concerns on its financial health. OCI is valued correctly, but it does not seem to be growing.



7

1. Profitability

1.1 Basic Checks

In the past year OCI was profitable.
OCI had a positive operating cash flow in the past year.
In multiple years OCI reported negative net income over the last 5 years.
In the past 5 years OCI always reported a positive cash flow from operatings.

1.2 Ratios

OCI has a Return On Assets of 4.60%. This is comparable to the rest of the industry: OCI outperforms 54.24% of its industry peers.
The Return On Equity of OCI (31.87%) is better than 98.31% of its industry peers.
Looking at the Return On Invested Capital, with a value of 28.06%, OCI belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for OCI is significantly above the industry average of 8.39%.
The 3 year average ROIC (18.88%) for OCI is below the current ROIC(28.06%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 4.6%
ROE 31.87%
ROIC 28.06%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)18.88%
ROIC(5y)12.91%

1.3 Margins

With a Profit Margin value of 3.95%, OCI perfoms like the industry average, outperforming 49.15% of the companies in the same industry.
The Operating Margin of OCI (20.44%) is better than 91.53% of its industry peers.
OCI's Operating Margin has improved in the last couple of years.
With a Gross Margin value of 25.34%, OCI is not doing good in the industry: 61.02% of the companies in the same industry are doing better.
OCI's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 20.44%
PM 3.95%
GM 25.34%
OM growth 3Y97.17%
OM growth 5Y30.18%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y48.19%
GM growth 5Y19.48%

4

2. Health

2.1 Basic Checks

OCI has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
Compared to 1 year ago, OCI has more shares outstanding
The number of shares outstanding for OCI has been increased compared to 5 years ago.
The debt/assets ratio for OCI has been reduced compared to a year ago.

2.2 Solvency

OCI has an Altman-Z score of 1.92. This is not the best score and indicates that OCI is in the grey zone with still only limited risk for bankruptcy at the moment.
With a Altman-Z score value of 1.92, OCI is not doing good in the industry: 72.88% of the companies in the same industry are doing better.
OCI has a debt to FCF ratio of 3.11. This is a good value and a sign of high solvency as OCI would need 3.11 years to pay back of all of its debts.
OCI has a better Debt to FCF ratio (3.11) than 88.14% of its industry peers.
A Debt/Equity ratio of 2.90 is on the high side and indicates that OCI has dependencies on debt financing.
Looking at the Debt to Equity ratio, with a value of 2.90, OCI is doing worse than 98.31% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 2.9
Debt/FCF 3.11
Altman-Z 1.92
ROIC/WACC5.97
WACC6.79%

2.3 Liquidity

OCI has a Current Ratio of 1.07. This is a normal value and indicates that OCI is financially healthy and should not expect problems in meeting its short term obligations.
OCI has a Current ratio of 1.07. This is amonst the worse of the industry: OCI underperforms 89.83% of its industry peers.
A Quick Ratio of 0.94 indicates that OCI may have some problems paying its short term obligations.
With a Quick ratio value of 0.94, OCI is not doing good in the industry: 66.10% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 1.07
Quick Ratio 0.94

2

3. Growth

3.1 Past

OCI shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -73.91%.
The Revenue for OCI has decreased by -14.19% in the past year. This is quite bad
The Revenue has been growing by 33.96% on average over the past years. This is a very strong growth!
EPS 1Y-73.91%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q-101.24%
Revenue growth 1Y-14.19%
Revenue growth 3Y47.42%
Revenue growth 5Y33.96%
Revenue growth Q2Q-47.09%

3.2 Future

OCI is expected to show a very negative growth in Earnings Per Share. In the coming years, the EPS will decrease by -29.43% yearly.
OCI is expected to show a very negative growth in Revenue. In the coming years, the Revenue will decrease by -13.37% yearly.
EPS Next Y-79.1%
EPS Next 2Y-41.08%
EPS Next 3Y-29.43%
EPS Next 5YN/A
Revenue Next Year-40.8%
Revenue Next 2Y-17.72%
Revenue Next 3Y-13.37%
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.

6

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 13.46, OCI is valued correctly.
Based on the Price/Earnings ratio, OCI is valued a bit cheaper than 64.41% of the companies in the same industry.
When comparing the Price/Earnings ratio of OCI to the average of the S&P500 Index (25.76), we can say OCI is valued slightly cheaper.
With a Price/Forward Earnings ratio of 12.59, OCI is valued correctly.
OCI's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. OCI is cheaper than 71.19% of the companies in the same industry.
OCI's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 18.85.
Industry RankSector Rank
PE 13.46
Fwd PE 12.59

4.2 Price Multiples

OCI's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. OCI is cheaper than 100.00% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, OCI is valued cheaply inside the industry as 98.31% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 4.38
EV/EBITDA 2.81

4.3 Compensation for Growth

The decent profitability rating of OCI may justify a higher PE ratio.
A cheap valuation may be justified as OCI's earnings are expected to decrease with -29.43% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-41.08%
EPS Next 3Y-29.43%

0

5. Dividend

5.1 Amount

OCI does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

OCI NV

AMS:OCI (9/29/2023, 7:00:00 PM)

26.39

+1.62 (+6.54%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap5.56B
Analysts73.68
Price Target32.45 (22.96%)
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)N/A
DP358.12%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-16.26%
Min EPS beat(2)-124.58%
Max EPS beat(2)92.06%
EPS beat(4)1
Avg EPS beat(4)-22.51%
Min EPS beat(4)-124.58%
Max EPS beat(4)92.06%
Revenue beat(2)2
Avg Revenue beat(2)154005%
Min Revenue beat(2)87579%
Max Revenue beat(2)220431%
Revenue beat(4)4
Avg Revenue beat(4)162222%
Min Revenue beat(4)87579%
Max Revenue beat(4)233884%
PT rev (1m)-0.89%
PT rev (3m)-7.85%
EPS NQ rev (1m)35.58%
EPS NQ rev (3m)-34.42%
EPS NY rev (1m)-8.38%
EPS NY rev (3m)-58.09%
Revenue NQ rev (1m)-99.89%
Revenue NQ rev (3m)-99.9%
Revenue NY rev (1m)1.82%
Revenue NY rev (3m)-15.2%
Valuation
Industry RankSector Rank
PE 13.46
Fwd PE 12.59
P/S 0.53
P/FCF 4.38
P/OCF 3.03
P/B 4.31
P/tB 6.79
EV/EBITDA 2.81
EPS(TTM)1.96
EY7.43%
EPS(NY)2.1
Fwd EY7.94%
FCF(TTM)6.02
FCFY22.83%
OCF(TTM)8.71
OCFY32.99%
SpS49.42
BVpS6.13
TBVpS3.89
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 4.6%
ROE 31.87%
ROCE 32.09%
ROIC 28.06%
ROICexc 36.74%
ROICexgc 40.51%
OM 20.44%
PM 3.95%
GM 25.34%
FCFM 12.19%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)18.88%
ROIC(5y)12.91%
ROICexc(3y)23.69%
ROICexc(5y)15.92%
ROICexgc(3y)25.73%
ROICexgc(5y)17.31%
ROCE(3y)21.59%
ROCE(5y)14.77%
ROICexcg growth 3Y210.97%
ROICexcg growth 5Y69.45%
ROICexc growth 3Y210.94%
ROICexc growth 5Y69.87%
OM growth 3Y97.17%
OM growth 5Y30.18%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y48.19%
GM growth 5Y19.48%
F-Score3
Asset Turnover1.16
Health
Industry RankSector Rank
Debt/Equity 2.9
Debt/FCF 3.11
Debt/EBITDA 1.38
Cap/Depr 97.72%
Cap/Sales 5.43%
Profit Quality 308.53%
Current Ratio 1.07
Quick Ratio 0.94
Altman-Z 1.92
F-Score3
WACC6.79%
ROIC/WACC5.97
Cap/Depr(3y)46.02%
Cap/Depr(5y)52.42%
Cap/Sales(3y)5.19%
Cap/Sales(5y)6.9%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
Growth
EPS 1Y-73.91%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q-101.24%
EPS Next Y-79.1%
EPS Next 2Y-41.08%
EPS Next 3Y-29.43%
EPS Next 5YN/A
Revenue growth 1Y-14.19%
Revenue growth 3Y47.42%
Revenue growth 5Y33.96%
Revenue growth Q2Q-47.09%
Revenue Next Year-40.8%
Revenue Next 2Y-17.72%
Revenue Next 3Y-13.37%
Revenue Next 5YN/A
EBIT growth 1Y-41.08%
EBIT growth 3Y190.67%
EBIT growth 5Y74.39%
EBIT Next Year-50.31%
EBIT Next 3Y-18.3%
EBIT Next 5YN/A
FCF growth 1Y29.56%
FCF growth 3Y328.7%
FCF growth 5Y143.66%
OCF growth 1Y59.73%
OCF growth 3Y114.88%
OCF growth 5Y79.1%